Concepedia

Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)

Christoph Rochlitz, Thomas Ruhstaller, Stefanie Lerch, Christian Spirig, Jens Huober, Thomas Suter, Monika Bühlmann, MK Fehr, A. Schönenberger, Roger von Moos,

Annals of Oncology · 2010 · 26 citations · 26 references

DOIFull text

Open access

Concepts

References

26

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +17

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

Herbert I. Hurwitz, Louis Fehrenbacher, William Novotny et al. · New England Journal of Medicine · 2004 · 10.9K citations · Full text

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

Alan Sandler, Robert J. Gray, Michael C. Perry et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text

Estimates of the cancer incidence and mortality in Europe in 2006

Jacques Ferlay, Philippe Autier, Mathieu Boniol et al. · Annals of Oncology · 2007 · 4K citations · Full text

, , +8

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

Kathy D. Miller, Molin Wang, Julie R. Gralow et al. · New England Journal of Medicine · 2007 · 3K citations · Full text